<DOC>
	<DOC>NCT00406003</DOC>
	<brief_summary>The study was designed to describe the relationship between dose and pharmacokinetic parameters of paroxetine over the range of proposed dosage strengths of the paroxetine CR tablet (12.5 to 37.5 mg) as well as safety profile</brief_summary>
	<brief_title>Single Dose Pharmacokinetic (PK) Study Of Paroxetine CR(12.5-37.5mg) In Healthy Chinese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<criteria>Inclusion criteria: 1945 years healthy Chinese Body weight &gt; 50 kg BMI between 1925 serological negative for HIV, syphilis and hepatitis B and C no abnormalities in ECG Female with negative pregnancy and male has no plan to have a child during and 3 months after the study. Exclusion criteria: History of chronic physical/mental disease, current disease and concomitant medication</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>BRL029060/Paroxetine CR</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>safety</keyword>
</DOC>